SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-496130"
 

Search: onr:"swepub:oai:DiVA.org:uu-496130" > Characteristics and...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00007651naa a2200793 4500
001oai:DiVA.org:uu-496130
003SwePub
008230209s2022 | |||||||||||000 ||eng|
0247 a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4961302 URI
0247 a https://doi.org/10.1002/acr2.114952 DOI
040 a (SwePub)uu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
1001 a Jatuworapruk, Kanonu Thammasat Univ, Bangkok, Thailand.4 aut
2451 0a Characteristics and Outcomes of People With Gout Hospitalized Due to COVID-19 :b Data From the COVID-19 Global Rheumatology Alliance Physician-Reported Registry
264 c 2022-08-24
264 1b John Wiley & Sons,c 2022
338 a electronic2 rdacarrier
520 a ObjectiveTo describe people with gout who were diagnosed with coronavirus disease 2019 (COVID-19) and hospitalized and to characterize their outcomes.MethodsData on patients with gout hospitalized for COVID-19 between March 12, 2020, and October 25, 2021, were extracted from the COVID-19 Global Rheumatology Alliance registry. Descriptive statistics were used to describe the demographics, comorbidities, medication exposures, and COVID-19 outcomes including oxygenation or ventilation support and death.ResultsOne hundred sixty-three patients with gout who developed COVID-19 and were hospitalized were included. The mean age was 63 years, and 85% were male. The majority of the group lived in the Western Pacific Region (35%) and North America (18%). Nearly half (46%) had two or more comorbidities, with hypertension (56%), cardiovascular disease (28%), diabetes mellitus (26%), chronic kidney disease (25%), and obesity (23%) being the most common. Glucocorticoids and colchicine were used pre-COVID-19 in 11% and 12% of the cohort, respectively. Over two thirds (68%) of the cohort required supplemental oxygen or ventilatory support during hospitalization. COVID-19-related death was reported in 16% of the overall cohort, with 73% of deaths documented in people with two or more comorbidities.ConclusionThis cohort of people with gout and COVID-19 who were hospitalized had high frequencies of ventilatory support and death. This suggests that patients with gout who were hospitalized for COVID-19 may be at risk of poor outcomes, perhaps related to known risk factors for poor outcomes, such as age and presence of comorbidity.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi0 (SwePub)303022 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Public Health, Global Health, Social Medicine and Epidemiology0 (SwePub)303022 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Reumatologi och inflammation0 (SwePub)302102 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Rheumatology and Autoimmunity0 (SwePub)302102 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Infektionsmedicin0 (SwePub)302092 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Infectious Medicine0 (SwePub)302092 hsv//eng
7001 a Montgomery, Annau Univ Calif San Francisco, San Francisco, CA 94143 USA.4 aut
7001 a Gianfrancesco, Milenau Univ Calif San Francisco, San Francisco, CA 94143 USA.4 aut
7001 a Conway, Richardu St James Hosp, Dublin, Ireland.;Trinity Coll Dublin, Dublin, Ireland.4 aut
7001 a Durcan, Laurau Beaumont Hosp, Dublin, Ireland.;Royal Coll Surgeons Ireland, Dublin, Ireland.4 aut
7001 a Graef, Elizabeth R.u Boston Univ, Sch Med, Boston, MA 02118 USA.4 aut
7001 a Jayatilleke, Aruniu Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA.4 aut
7001 a Keen, Helenu Univ Western Australia, Perth, WA, Australia.4 aut
7001 a Kilian, Adamu St Louis Univ, Sch Med, St Louis, MO USA.4 aut
7001 a Young, Kristenu Univ Arizona, Coll Med, Phoenix, AZ USA.4 aut
7001 a Carmona, Loretou Inst Salud Musculoesquelet, Madrid, Spain.4 aut
7001 a Cogo, Adriana Karinau Hosp Interzonal Luis Guemes, Buenos Aires, DF, Argentina.;Hosp San Juan Dios, Buenos Aires, DF, Argentina.4 aut
7001 a Duarte-Garcia, Aliu Mayo Clin, Rochester, MN USA.4 aut
7001 a Gossec, Laureu Sorbonne Univ, INSERM, Inst Pierre Louis Epidemiol & Sante Publ, Paris, France.;Hop La Pitie Salpetriere, AP HP, Paris, France.4 aut
7001 a Hasseli, Rebeccau Justus Liebig Univ Giessen, Univ Hosp Giessen, Giessen, Germany.4 aut
7001 a Hyrich, Kimme L.u Univ Manchester, Manchester, Lancs, England.;Manchester Univ NHS Fdn Trust, Natl Inst Hlth Res, Manchester Biomed Res Ctr, Manchester, Lancs, England.4 aut
7001 a Langlois, Vincentu Grp Hosp Havre, Le Havre, France.4 aut
7001 a Lawson-Tovey, Saskiau Univ Manchester, Manchester, Lancs, England.4 aut
7001 a Malcata, Armandou Ctr Hosp & Univ Coimbra, Serv Reumatol, Lisbon, Portugal.;Soc Portuguesa Reumatol, Reumapt, Lisbon, Portugal.4 aut
7001 a Mateus, Elsa F.u Portuguese League Rheumat Dis LPCDR, Lisbon, Portugal.4 aut
7001 a Schafer, Martinu German Rheumatism Res Ctr Berlin DRFZ, Epidemiol & Hlth Care Res, Berlin, Germany.4 aut
7001 a Scire, Carlo Albertou Italian Soc Rheumatol, Milan, Italy.4 aut
7001 a Sigurdardottir, Valgerduru Uppsala universitet,Centrum för klinisk forskning Dalarna4 aut0 (Swepub:uu)valsi334
7001 a Sparks, Jeffrey A.u Brigham & Womens Hosp, Boston, MA USA.;Harvard Med Sch, Boston, MA 02115 USA.4 aut
7001 a Strangfeld, Anjau German Rheumatism Res Ctr Berlin DRFZ, Epidemiol & Hlth Care Res, Berlin, Germany.4 aut
7001 a Xavier, Ricardo M.u Univ Fed Rio Grande do Sul UFRGS, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.4 aut
7001 a Bhana, Sulemanu Pfizer Inc, New York, NY USA.4 aut
7001 a Gore-Massy, Moniqueu Lupus Fdn Amer, Washington, DC USA.4 aut
7001 a Hausmann, Jonathanu Beth Israel Deaconess Med Ctr, Boston Childrens Hosp, Boston, MA 02215 USA.4 aut
7001 a Liew, Jean W.u Boston Univ, Sch Med, Boston, MA 02118 USA.4 aut
7001 a Sirotich, Emilyu McMaster Univ, Canada Canadian Arthrit Patient Alliance, Hamilton, ON, Canada.4 aut
7001 a Sufka, Paulu HealthPartners, St Paul, MN USA.4 aut
7001 a Wallace, Zachu Harvard Med Sch, Boston, MA 02115 USA.;Massachusetts Gen Hosp, Boston, MA 02114 USA.4 aut
7001 a Machado, Pedro M.u UCL, London, England.;Univ Coll London Hosp NHS Fdn Trust, Univ Coll London Hosp Biomed Res Ctr, Natl Inst Hlth Res NIHR, London, England.;London North West Univ Healthcare NHS Trust, Northwick Pk Hosp, London, England.4 aut
7001 a Yazdany, Jinoosu Univ Calif San Francisco, San Francisco, CA 94143 USA.4 aut
7001 a Grainger, Rebeccau Univ Otago Wellington, Wellington, New Zealand.4 aut
7001 a Robinson, Philip C.u Royal Brisbane & Womens Hosp, Herston, Qld, Australia.;Univ Queensland, Sch Clin Med, Herston, Qld, Australia.4 aut
7102 a Thammasat Univ, Bangkok, Thailand.b Univ Calif San Francisco, San Francisco, CA 94143 USA.4 org
7730 t ACR Open Rheumatologyd : John Wiley & Sonsg 4:11, s. 948-953q 4:11<948-953x 2578-5745
8564 u https://doi.org/10.1002/acr2.11495y Fulltext
8564 u https://uu.diva-portal.org/smash/get/diva2:1735571/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-496130
8564 8u https://doi.org/10.1002/acr2.11495

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view